Associations between genetically predicted plasma N-glycans and pancreatic cancer risk

[1]  Y. Aulchenko,et al.  Twelve Years of Genome-Wide Association Studies of Human Protein N-Glycosylation , 2023, Engineering.

[2]  R. Tollenaar,et al.  Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals. , 2022, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[3]  C. Doglioni,et al.  Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies , 2022, Science Translational Medicine.

[4]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[5]  Chong Wu,et al.  Associations Between Genetically Predicted Protein Levels and COVID-19 Severity , 2020, The Journal of infectious diseases.

[6]  T. Spector,et al.  Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases , 2020, Science Advances.

[7]  T. Donahue,et al.  Pancreatic Cancer. , 2019, JAMA.

[8]  Y. Mechref,et al.  Revealing the Biological Attributes of N-Glycan Isomers in Breast Cancer Brain Metastasis Using Porous Graphitic Carbon (PGC) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). , 2019, Journal of proteome research.

[9]  R. Drake,et al.  Core-Fucosylated Tetra-Antennary N-Glycan Containing A Single N-Acetyllactosamine Branch Is Associated with Poor Survival Outcome in Breast Cancer , 2019, International journal of molecular sciences.

[10]  G. D. da Rocha,et al.  Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles , 2019, Scientific Reports.

[11]  N. Packer,et al.  Translating N‐Glycan Analytical Applications into Clinical Strategies for Ovarian Cancer , 2018, Proteomics. Clinical applications.

[12]  Jeffery M. Meyer,et al.  Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. , 2018, International journal of epidemiology.

[13]  Jeffery M. Meyer,et al.  A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer , 2018, Nature Genetics.

[14]  Christopher J. Gregg,et al.  Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk , 2018, PloS one.

[15]  Fergal J. Duffy,et al.  Plasma N-glycans in colorectal cancer risk , 2018, Scientific Reports.

[16]  Elena Papaleo,et al.  N‐glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome , 2018, Molecular oncology.

[17]  K. Tanabe,et al.  Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker , 2018, BMC Cancer.

[18]  Teresa J. Feo,et al.  Structural absorption by barbule microstructures of super black bird of paradise feathers , 2018, Nature Communications.

[19]  Gary D Bader,et al.  Association analysis identifies 65 new breast cancer risk loci , 2017, Nature.

[20]  S. Inamdar,et al.  High mannose N-glycan binding lectin from Remusatia vivipara (RVL) limits cell growth, motility and invasiveness of human breast cancer cells. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  Linhong Deng,et al.  Conditioned Medium from Malignant Breast Cancer Cells Induces an EMT-Like Phenotype and an Altered N-Glycan Profile in Normal Epithelial MCF10A Cells , 2017, International journal of molecular sciences.

[22]  T. Habuchi,et al.  An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis , 2017, International journal of molecular sciences.

[23]  Hao Wang,et al.  Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer , 2017, Clinical and Experimental Medicine.

[24]  Christian Gieger,et al.  Connecting genetic risk to disease end points through the human blood plasma proteome , 2016, Nature Communications.

[25]  C. Gieger,et al.  ‘Omics’ biomarkers associated with chronic low back pain: protocol of a retrospective longitudinal study , 2016, BMJ Open.

[26]  W. Hancock,et al.  Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry. , 2016, Accounts of chemical research.

[27]  Pauline M. Rudd,et al.  Glycosylation of plasma IgG in colorectal cancer prognosis , 2016, Scientific Reports.

[28]  N. Taniguchi,et al.  Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer , 2016, Biomolecules.

[29]  D. Elliott,et al.  Hallmarks of glycosylation in cancer , 2016, Oncotarget.

[30]  Young Hwan Kim,et al.  Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis. , 2015, Carbohydrate research.

[31]  S. Pinho,et al.  Glycosylation in cancer: mechanisms and clinical implications , 2015, Nature Reviews Cancer.

[32]  Chengwen Sun,et al.  Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy. , 2015, Journal of proteome research.

[33]  J. Leek.  svaseq: removing batch effects and other unwanted noise from sequencing data , 2014, bioRxiv.

[34]  Congjian Xu,et al.  Discovery of Specific Metastasis-Related N-Glycan Alterations in Epithelial Ovarian Cancer Based on Quantitative Glycomics , 2014, PloS one.

[35]  Thomas Kocher,et al.  1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. , 2014, The Journal of clinical endocrinology and metabolism.

[36]  M. Fang,et al.  The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric Cancer , 2013, PloS one.

[37]  P. Visscher,et al.  Calculating statistical power in Mendelian randomization studies. , 2013, International journal of epidemiology.

[38]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[39]  Archie Campbell,et al.  Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. , 2013, International journal of epidemiology.

[40]  C. Lebrilla,et al.  Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. , 2013, Journal of chromatography. A.

[41]  Jeanine J. Houwing-Duistermaat,et al.  Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers , 2013, PLoS genetics.

[42]  Alireza Moayyeri,et al.  The UK Adult Twin Registry (TwinsUK Resource) , 2012, Twin Research and Human Genetics.

[43]  Kelley W. Moremen,et al.  Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.

[44]  C. Lebrilla,et al.  Application of nano-LC-based glycomics towards biomarker discovery. , 2011, Bioanalysis.

[45]  C. Lebrilla,et al.  Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. , 2011, The Analyst.

[46]  K. Ohtsubo,et al.  Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. , 2009, Carbohydrate research.

[47]  D. Foell,et al.  RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis , 2008, Carcinogenesis.

[48]  J. Gu,et al.  Branched N‐glycans regulate the biological functions of integrins and cadherins , 2008, The FEBS journal.

[49]  S. Hakomori,et al.  Glycosylation defining cancer malignancy: New wine in an old bottle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Dennis,et al.  Suppression of tumor growth and metastasis in Mgat5-deficient mice , 2000, Nature Medicine.

[51]  W. Chaney,et al.  Control of metastasis by Asn-linked, beta1-6 branched oligosaccharides in mouse mammary cancer cells. , 1999, Glycobiology.

[52]  N. Taniguchi,et al.  Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Dennis,et al.  Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V , 1995, The Journal of cell biology.

[54]  B. Sergeyev,et al.  Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival , 2011, Glycoconjugate Journal.